secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001213900-22-078586
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Actinium adjourns 2022 annual meeting to Dec 30 for more stockholder voting
---------------------------------------------------------------------------

- Meeting originally scheduled Dec 8, 2022 adjourned to allow more time for voting.
- Reconvened meeting set for Dec 30, 2022 at 9:30 a.m. ET in Garden City, NY.
- Proxies previously submitted will be voted at reconvened meeting unless revoked.
- Stockholders who haven't voted can vote via internet, phone, or mail by Dec 29.
- Alliance Advisors assisting with proxy solicitation; stockholders can call for help.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390022078586/0001213900-22-078586-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390022078586/ea169895-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-078586

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer